课题基金 / 基金详情

Development of therapeutic agents that target carbonic anhydrase enzymes

Development of therapeutic agents that target carbonic anhydrase enzymes
开发针对碳酸酐酶的治疗剂
批准号:
DP0877554
负责人:
Prof Sally-Ann Poulsen
金额:
$26.08万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2011-12-31

项目摘要

项目成果

Prof Sally-Ann Poulsen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research will discover new chemical entities (compounds) that may lead to therapies for the treatment of cancer, glaucoma and malaria. The research underpins a mechanism to add value to our compounds before partnering with industry to transform the discoveries made here to deliverable therapies that could benefit the health of millions, thus offering a potentially high value contribution to the Australian economy. The experience and commitment of the multi-disciplinary network of researchers offers exceptional training and employment opportunities for tomorrow's scientists in techniques for discovery and characterisation of novel chemicals, and their interaction with disease targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical probes to dissect the cell cycle of globally important parasites
  • 批准号:
    DP220102618
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.9万
  • 财政年份:
    2022
  • 负责人:
    Prof Sally-Ann Poulsen
  • 依托单位:
Chemical probes for visualising DNA synthesis
  • 批准号:
    DP180102601
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.79万
  • 财政年份:
    2018
  • 负责人:
    Prof Sally-Ann Poulsen
  • 依托单位:
Acoustic liquid handling robotics for bioactive compound discovery
  • 批准号:
    LE170100075
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $21.0万
  • 财政年份:
    2017
  • 负责人:
    Prof Sally-Ann Poulsen
  • 依托单位:
Selectively targeting cancer and infectious disease with fragment-based drug discovery
  • 批准号:
    DP140101495
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $27.24万
  • 财政年份:
    2014
  • 负责人:
    Prof Sally-Ann Poulsen
  • 依托单位:
国内基金
海外基金
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
  • 批准号:
    82371809
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    聂红
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: